Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S Wahed

Showing results (71-80 of 120) with videos related to

Pageof 12
Sort By:
Alimentary Pharmacology & Therapeutics|January 17, 2020
Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysisDonna M Evon, Hsing-Hua S Lin, Mandana Khalili, et al.
Plos One|October 11, 2019
Correction: Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trialVictor J Navarro, Steven H Belle, Massimo D'Amato, et al.
Plos One|September 20, 2019
Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trialVictor J Navarro, Steven H Belle, Massimo D'Amato, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 24, 2019
The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 DiabetesAllon N Friedman, Junyao Wang, Abdus S Wahed, et al.
Digestive Diseases and Sciences|February 3, 2016
Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN)Donna M Evon, Abdus S Wahed, Geoffrey Johnson, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis CLeland J Yee, KyungAh Im, Abdus S Wahed, et al.
Clinical Trials (London, England)|November 8, 2011
Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis CK Rajender Reddy, Steven H Belle, Michael W Fried, et al.
JAMA|July 17, 2012
Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trialMichael W Fried, Victor J Navarro, Nezam Afdhal, et al.
Intervirology|April 30, 2009
Host genetics, steatosis and insulin resistance among African Americans and Caucasian Americans with hepatitis C virus genotype-1 infectionA Danielle Iuliano, Eleanor Feingold, Abdus S Wahed, et al.
JAMA|September 23, 2016
Effect of Wearable Technology Combined With a Lifestyle Intervention on Long-term Weight Loss: The IDEA Randomized Clinical TrialJohn M Jakicic, Kelliann K Davis, Renee J Rogers, et al.
Pageof 12

Showing results (71-80 of 120) with videos related to

Sort By:
Pageof 12
Alimentary Pharmacology & Therapeutics|January 17, 2020
Patient-reported outcomes in a large North American cohort living with chronic hepatitis B virus: a cross-sectional analysisDonna M Evon, Hsing-Hua S Lin, Mandana Khalili, et al.
Plos One|October 11, 2019
Correction: Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trialVictor J Navarro, Steven H Belle, Massimo D'Amato, et al.
Plos One|September 20, 2019
Silymarin in non-cirrhotics with non-alcoholic steatohepatitis: A randomized, double-blind, placebo controlled trialVictor J Navarro, Steven H Belle, Massimo D'Amato, et al.
American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation|July 24, 2019
The Association Between Kidney Disease and Diabetes Remission in Bariatric Surgery Patients With Type 2 DiabetesAllon N Friedman, Junyao Wang, Abdus S Wahed, et al.
Digestive Diseases and Sciences|February 3, 2016
Fatigue in Patients with Chronic Hepatitis B Living in North America: Results from the Hepatitis B Research Network (HBRN)Donna M Evon, Abdus S Wahed, Geoffrey Johnson, et al.
Antimicrobial Agents and Chemotherapy|October 15, 2008
Polymorphism in the human major histocompatibility complex and early viral decline during treatment of chronic hepatitis CLeland J Yee, KyungAh Im, Abdus S Wahed, et al.
Clinical Trials (London, England)|November 8, 2011
Rationale, challenges, and participants in a Phase II trial of a botanical product for chronic hepatitis CK Rajender Reddy, Steven H Belle, Michael W Fried, et al.
JAMA|July 17, 2012
Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis C unsuccessfully treated with interferon therapy: a randomized controlled trialMichael W Fried, Victor J Navarro, Nezam Afdhal, et al.
Intervirology|April 30, 2009
Host genetics, steatosis and insulin resistance among African Americans and Caucasian Americans with hepatitis C virus genotype-1 infectionA Danielle Iuliano, Eleanor Feingold, Abdus S Wahed, et al.
JAMA|September 23, 2016
Effect of Wearable Technology Combined With a Lifestyle Intervention on Long-term Weight Loss: The IDEA Randomized Clinical TrialJohn M Jakicic, Kelliann K Davis, Renee J Rogers, et al.
Pageof 12